Search results
Results from the WOW.Com Content Network
Botulinum toxin, or botulinum neurotoxin (commonly called botox), is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. [24] It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction , thus causing flaccid paralysis . [ 25 ]
Along with some strains of Clostridium butyricum and Clostridium baratii, these bacteria all produce the toxin. [2] Botulinum toxin can cause botulism, a severe flaccid paralytic disease in humans and other animals, [3] and is the most potent toxin known to science, natural or synthetic, with a lethal dose of 1.3–2.1 ng/kg in humans. [4] [5]
In all cases, illness is caused by the botulinum toxin which the bacterium C. botulinum produces in anaerobic conditions and not by the bacterium itself. The pattern of damage occurs because the toxin affects nerves that fire (depolarize) at a higher frequency first. [12] Mechanisms of entry into the human body for botulinum toxin are described ...
They may exert their effect locally or produce systemic effects. Well-known exotoxins include: botulinum toxin produced by Clostridium botulinum; Corynebacterium diphtheriae toxin, produced during life-threatening symptoms of diphtheria; tetanospasmin produced by Clostridium tetani.
Toxin Source of toxin (military symbol) Abrin: Rosary pea (Abrus precatorius) Botulinum toxins (A through G) Clostridium botulinum bacteria or spores, and several other Clostridial species. (X or XR) Ricin: Castor bean (Ricinus communis) (W or WA) Saxitoxin
Botulinum toxin is a neurotoxic ingredient used in injections to temporarily freeze facial muscles to prevent the movements and expressions that exacerbate wrinkles. It’s the active ingredient ...
BAT is the only FDA-approved product available for treating botulism in adults, and for botulism in infants caused by botulinum toxins other than types A and B. BAT has been used to treat a case of type F infant botulism and, on a case-by-case basis, may be used for future cases of non-type A and non-type B infant botulism.
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using GLP-1 drugs such as Ozempic and Wegovy after losing weight.